Decoding OpenAI’s Super Bowl ad and Sam Altman’s grandiose blog post
Critics of OpenAI would say it’s more empty hype designed to continue placating OpenAI’s big-pocketed investors.
Related Articles
Nerandomilast Meets Primary Endpoint in Improving FVC in Progressive Pulmonary Fibrosis
Boehringer plans to soon submit a new drug application for nerandomilast for treating PPF to the FDA.
Meta’s AI randomly tried to throw a weird party for me—that I never asked for
After I made a quip on Facebook about a Super Bowl ad, Meta’s AI curiously created a party invitation for me—and Puppy Monkey Baby.
Travere Therapeutics Plans FSGS Submission for Sparsentan
An approval for sparsentan in focal segmental glomerulosclerosis would mark the second rare kidney disease approval for the agent.
Prevalence of cardiovascular symptoms in post-acute COVID-19 syndrome: a meta-analysis – BMC Medicine
Background Since its emergence in 2019, COVID-19 has continued to pose significant threats to both the physical and mental health of the global population, as…
Is AI making us dumb? | TechCrunch
Researchers from Microsoft and Carnegie Mellon University recently published a study looking at how using generative AI at work affects critical thinking
Hijacking of the nervous system in cancer: mechanism and therapeutic targets – Molecular Cancer
The activity of neurons in the vicinity of tumors is linked to a spectrum of cellular mechanisms, including the facilitation of tumor cell proliferation, synapse…
Multidisciplinary Rehab Team Helps Patient Make Full Recovery From Severe Ski Accident
How neurorehabilitation at Cleveland Clinic London Hospital enabled a 34-year-old to fully recover from traumatic brain injury following devastating ski accident
How RFK Jr. could revive a dormant task force to scrutinize vaccine safety
As health secretary, Kennedy could revive a defunct task force to scrutinize the safety of shots given to babies and kids.
22 States Sue to Block Trump Cuts to Medical Research Funding
A coalition of attorneys general sued the federal government Monday, claiming that the $4 billion in cuts would “grind to a halt” studies on cancer,…
